Genzyme Therapeutic Products Limited Partnership
H‑1B Sponsor Verified
Yes. Genzyme Therapeutic Products Limited Partnership filed 36 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2019–2026, including 5 so far in 2026. The average H-1B salary is $103,876 and the most sponsored role is Quality Engineer Principal.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: May 27, 2026.
LinkedIn ↗Latest Year Filings
5
In 2026
↗ Filter by year
Total H‑1B Filings
36
Since 2020
↗ View records
Avg Annual Salary
$103,876
All years combined
↗ View chart
Top Role
Quality Engineer Principal
↗ Click to filter
Filing trend
H‑1B filings by year for Genzyme Therapeutic Products Limited Partnership
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 5 | $102,678 |
| 2025 | 6 | $130,059 |
| 2024 | 3 | $111,550 |
| 2023 | 3 | $76,803 |
| 2022 | 6 | $122,304 |
| 2021 | 1 | $85,966 |
| 2020 | 8 | $91,625 |
| 2019 | 4 | $81,988 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary